CANCER BIOLOGY & THERAPY

Journal Title

CANCER BIOLOGY & THERAPY

CANCER BIOL THER

ISSN / eISSN

1538-4047 / 1555-8576

Aims and Scope

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.

Subject Area

ONCOLOGY

CiteScore

9.80 View Trend

CiteScore Ranking

Category	Quartile	Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology	Q1	#38/301
Pharmacology, Toxicology and Pharmaceutics - Oncology	Q1	#51/366
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine	Q1	#35/171
Pharmacology, Toxicology and Pharmaceutics - Cancer Research	Q1	#47/214

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
ONCOLOGY - SCIE	Q2

H-index

101

Country/Area of Publication

UNITED STATES

Publisher

Landes Bioscience

Publication Frequency

Monthly

Year Publication Started

2002

Annual Article Volume

61

Open Access

NO

Contact

LANDES BIOSCIENCE, 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, USA, TX, 78701